XENE
Xenon Pharmaceuticals Inc
36.90$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 79.1% | 66.8% | 77.0% | 82.4% | 78.9% | 79.6% | 76.1% | 74.2% | 79.0% | 57.1% | 79.8% | 73.0% | |
| 14.8% | 15.4% | 6.4% | 15.5% | 10.5% | 17.9% | 15.7% | 20.1% | 17.2% | 20.3% | 39.4% | 9.2% | |
| 78.5% | 66.1% | 76.1% | 81.6% | 78.2% | 78.5% | 73.9% | 72.3% | 76.1% | 55.9% | 78.9% | 71.8% | |
| 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 1.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | |
| -0.1% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 5.1% | 3.8% | 3.4% | 4.5% | 4.6% | 5.4% | 5.3% | 6.0% | 8.0% | 40.7% | 3.5% | 4.1% | |
| 3.7% | 2.8% | 2.4% | 3.5% | 3.6% | 4.5% | 4.3% | 4.9% | 6.3% | 4.3% | 2.9% | 3.5% | |
| 0.2% | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | |
| 0.9% | 0.9% | 0.7% | 1.1% | 0.6% | 0.6% | 0.9% | 0.7% | 0.7% | 0.4% | 0.4% | 0.2% | |
| 94.9% | 96.2% | 96.6% | 95.5% | 95.4% | 94.6% | 94.7% | 94.0% | 92.0% | 59.3% | 96.5% | 95.9% | |
| -92.4% | -68.9% | -77.6% | -87.2% | -99.7% | -112.7% | -129.8% | -155.6% | -187.6% | -126.9% | -97.2% | -112.6% | |
| 9.8% | 7.3% | 8.4% | 8.8% | 9.3% | 9.8% | 10.6% | 11.7% | 13.0% | 8.1% | 6.3% | 7.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.